Feb 22, 2018

Mini lab-created organs successfully check cancer treatments

Microscopic images of lab-grown organoids from a patient with metastatic gastroesophageal cancer. Photo: George Vlachogiannis / Institute of Cancer Research at the Royal Cancer Hospital

Scientists used lab-grown cells from an individual's cancer tumor to study their response to different drugs, according to a new study published in Science Thursday.

Why it matters: These cells, called organoids, bring us a step toward honing precision medicine for patients with aggressive, metastatic gastrointestinal cancers.

"It could allow clinicians not only to test known anticancer drugs but also other drugs that are not being used in cancer but that could be re-purposed for that particular patient."
— Meritxell Huch of the University of Cambridge's Gurdon Institute

Hans Clevers, group leader at the Hubrecht Institute for Developmental Biology and Stem Cell Research, who was not part of this study but helped create the organoid technique used in this trial, tells Axios:

"It proves beyond a doubt that cancer organoids can be used to predict drug response in a personalized fashion. We have given some anecdotal evidence earlier, but nothing to the level of this paper."

What they did during the 3-year trial:

  • The researchers took 110 fresh tumor biopsies from 71 gastrointestinal patients and used them to create patient-derived organoids.
  • They compared the organoids with the original tumors to check they were similar.
  • They investigated the robustness of organoids as a screening platform for drug discoveries, and compared head-to-head the organoid response with the patient's response in the clinic.
  • It took roughly 6–8 weeks from biopsy to obtain the drug results.

What they found: The team found 88% positive predictive value (ability to identify responsive drugs) and 100% negative predictive value (ability to identify non-responsive drugs) in forecasting response to targeted agents or chemotherapy in patients.

"The organoids could recapitulate (ex vivo) patients' treatment responses to all currently approved anti-cancer treatment regimens used for metastatic colorectal cancers. The fact that these observations were not restricted to certain treatment was suggestive of the robustness of our experimental approach, but more importantly of the power this system may have in predicting clinical responses, which can have major clinical implications for personalized medicine."
— George Vlachogiannis, study author from the Institute of Cancer Research in London

More: They found if a sample doesn't have a lot of tumor cells — which means it's hard to get good results via genomic sequencing — organoids can still be grown to help make a diagnosis.

"This is per se very important as it allows performing an accurate genetic analysis of the tumor even in those cases where this is not possible from the tumor biopsy directly," Huch tells Axios.

Limitations: Emile Voest, who was not part of this study, says more research on the variety of drugs and on a greater number of patients is needed before it can be decided if there is potential clinical applications.

"This is the next challenge for the field: are tumor organoids able to be used as a predictive test to select or avoid a treatment."
— Voest, medical director of the executive board of the Netherlands Cancer Institute

Vlachogiannis agrees and adds:

"One needs to remember that cancer is a very complex disease, and that various tumor lesions within the same patient respond differently to treatment. ... Establishing organoid cultures from circulating tumor cells may be a better way to capture cancer heterogeneity within the patient...and efforts should be put in that direction as well."

Go deeper

U.S. coronavirus updates

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Andrew Witherspoon/Axios. This graphic includes "probable deaths" that New York City began reporting on April 14.

More than 62,300 U.S. health care workers have tested positive for the novel coronavirus and at least 291 have died from the virus, the Centers for Disease Control and Prevention reported on Tuesday. COVID-19 had infected about 9,300 health professionals when the CDC gave its last update on April 17.

By the numbers: More than 98,900 people have died from COVID-19 and over 1.6 million have tested positive in the U.S. Over 384,900 Americans have recovered and more than 14.9 million tests have been conducted.

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 11:00 p.m. ET: 5,589,626 — Total deaths: 350,453 — Total recoveries — 2,286,956Map.
  2. U.S.: Total confirmed cases as of 11:00 p.m. ET: 1,680,913 — Total deaths: 98,913 — Total recoveries: 384,902 — Total tested: 14,907,041Map.
  3. Federal response: DOJ investigates meatpacking industry over soaring beef pricesMike Pence's press secretary returns to work.
  4. Congress: House Republicans to sue Nancy Pelosi in effort to block proxy voting.
  5. Business: How the new workplace could leave parents behind.
  6. Tech: Twitter fact-checks Trump's tweets about mail-in voting for first timeGoogle to open offices July 6 for 10% of workers.
  7. Public health: Coronavirus antibodies could give "short-term immunity," CDC says, but more data is neededCDC releases guidance on when you can be around others after contracting the virus.
  8. What should I do? When you can be around others after contracting the coronavirus — Traveling, asthma, dishes, disinfectants and being contagiousMasks, lending books and self-isolatingExercise, laundry, what counts as soap — Pets, moving and personal healthAnswers about the virus from Axios expertsWhat to know about social distancingHow to minimize your risk.
  9. Other resources: CDC on how to avoid the virus, what to do if you get it, the right mask to wear.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Updated 41 mins ago - Politics & Policy

World coronavirus updates

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Axios Visuals

There are no COVID-19 patients in hospital in New Zealand, which reported just 21 active cases after days of zero new infections. A top NZ health official said Tuesday he's "confident we have broken the chain of domestic transmission."

By the numbers: Almost 5.5 million people have tested positive for the novel coronavirus as of Tuesday, and more than 2.2 million have recovered. The U.S. has reported the most cases in the world (over 1.6 million from 14.9 million tests).